GlassScriptPhysician profile
Kimberly A Smith
NPI 1134593601
$1,209.57
in general payments reported to CMS, 2019-2025
19 companies · $721 in 2025
The $721 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $126 · 2023: $48.87 · 2024: $313 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $187.82 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $158.04 | 2022-2023 | Imbruvica |
| Lilly USA, LLC | $155.38 | 2024-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $131.33 | 2024-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $123.51 | 2025 | Ozempic, Wegovy, Rybelsus |
| Alexion Pharmaceuticals, INC. | $57.92 | 2024-2025 | Strensiq |
| Pfizer INC. | $44.41 | 2025 | |
| Sanofi-Aventis U.S. LLC | $42.50 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $42.48 | 2024-2025 | Gvoke Hypopen |
| Collegium Pharmaceutical, INC. | $39.50 | 2025 | Jornay Pm |
| Corcept Therapeutics | $37.76 | 2025 | Korlym |
| Mimedx Group, INC. | $37.15 | 2025 | |
| Janssen Pharmaceuticals, INC | $35.19 | 2024 | Spravato |
| Exact Sciences Corporation | $21.48 | 2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $20.94 | 2024 | Arexvy, Shingrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $20.40 | 2025 | Auvelity |
| Kyowa Kirin, INC. | $18.91 | 2024 | Crysvita |
| Phathom Pharmaceuticals, INC. | $17.67 | 2024 | Voquezna |
| Organon LLC | $17.18 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.